methyl palmitate has been researched along with Cirrhoses, Experimental Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, AS; El-Demerdash, E; Hassan, DA; Mantawy, EM; Tadros, MG | 1 |
1 other study(ies) available for methyl palmitate and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Insights antifibrotic mechanism of methyl palmitate: impact on nuclear factor kappa B and proinflammatory cytokines.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbon Tetrachloride; Cytokines; Liver; Liver Cirrhosis, Experimental; Male; NF-kappa B; Oxidative Stress; Palmitates; Rats | 2012 |